General

Deuruxolitinib significantly improves scalp hair regrowth in alopecia areata

Deuruxolitinib was found to significantly improve scalp hair regrowth in alopecia areata, according to data from its Phase 3 clinical trial, THRIVE-AA2, presented at the American Academy of Dermatology's (AAD) 2023 Annual Meeting Late Breaking News Session. The primary efficacy endpoint of the trial was the percentage of patients achieving...